T-cell-mediated immunity in thyroid-associated ophthalmopathy

被引:18
作者
Bednarczuk, T
Hiromatsu, Y
Inoue, Y
Yamamoto, K
Wall, JR
Nauman, J
机构
[1] Polish Acad Sci, Med Res Ctr, Dept Endocrinol, PL-02097 Warsaw, Poland
[2] Med Univ Warsaw, Warsaw, Poland
[3] Kurume Univ, Sch Med, Dept Endocrinol & Metab, Kurume, Fukuoka 830, Japan
[4] Olympia Eye Hosp, Tokyo, Japan
[5] Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Tokyo, Japan
[6] Queen Elizabeth 2 Hlth Sci Ctr, Halifax, NS, Canada
关键词
D O I
10.1089/105072502753600151
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Thyroid-associated ophthalmopathy (TAO) is considered to be an autoimmune inflammatory disorder of the extraocular muscles and the orbital fat/connective tissue. Recent studies analyzing T cells infiltrating retrobulbar tissues generated important insights into the immunopathogenesis of TAO. The present review focuses on advances in our understanding of mechanisms responsible for the autoimmune inflammation in TAO, especially T cell migration to the inflammatory site, T cell activation by autoantigens and costimulatory signals and their cytokine profile. The elucidation of these processes might lead to the development of novel therapeutic strategies directed against autoreactive T cells.
引用
收藏
页码:209 / 215
页数:7
相关论文
共 47 条
[1]   Relationship between disease duration and predominant orbital T cell subset in Graves' ophthalmopathy [J].
Aniszewski, JP ;
Valyasevi, RW ;
Bahn, RS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (02) :776-780
[2]  
Arnold K, 1996, ORBIT, V15, P159, DOI 10.3109/01676839609150233
[3]   Chemokines and leukocyte traffic [J].
Baggiolini, M .
NATURE, 1998, 392 (6676) :565-568
[4]   Autoantibodies reactive with extracellular matrix proteins in patients with thyroid-associated ophthalmopathy [J].
Bednarczuk, T ;
Stolarski, C ;
Pawlik, E ;
Slon, M ;
Rowinski, M ;
Kubota, S ;
Hiromatsu, Y ;
Bartoszewicz, Z ;
Wall, JR ;
Nauman, J .
THYROID, 1999, 9 (03) :289-295
[5]   T cell interactions with extracellular matrix proteins in patients with thyroid-associated ophthalmopathy [J].
Bednarczuk, T ;
Kiljanski, J ;
Mrowiec, T ;
Slon, M ;
Ing, E ;
Stolarski, C ;
Kennerdell, JS ;
Gorski, A ;
Nauman, J ;
Wall, JR .
AUTOIMMUNITY, 1998, 27 (04) :221-230
[6]  
BEDNARCZUK T, 1997, THYROID DIS ENDOCRIN, P341
[7]   GRAVES OPHTHALMOPATHY - CURRENT CONCEPTS REGARDING PATHOGENESIS AND MANAGEMENT [J].
BURCH, HB ;
WARTOFSKY, L .
ENDOCRINE REVIEWS, 1993, 14 (06) :747-793
[8]   CYTOLYTIC T-CELLS WITH TH1-LIKE CYTOKINE PROFILE PREDOMINATE IN RETROORBITAL LYMPHOCYTIC INFILTRATES GRAVES OPHTHALMOPATHY [J].
DECARLI, M ;
DELIOS, MM ;
MARIOTTI, S ;
MARCOCCI, C ;
PINCHERA, A ;
RICCI, M ;
ROMAGNANI, S ;
DELPRETE, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (05) :1120-1124
[9]  
Förster G, 1998, CLIN EXP IMMUNOL, V112, P427
[10]   The expression of the beta 1 integrin CD29 and the beta 2 integrin CD11b is decreased in peripheral blood lymphocytes from Graves' disease patients [J].
Girón, JA ;
Rojano, J ;
Sasián, S ;
Gavilán, I ;
Aguilar, M ;
Escobar, L .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1998, 139 (03) :349-354